Welcome to our dedicated page for FULLER H B CO SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
H.B. Fuller Company filings document formal disclosures for a Minnesota-based public company that manufactures and sells adhesives, sealants and chemical-based products. Current reports furnish quarterly and fiscal-year operating results, including revenue, margin, adjusted EBITDA and guidance disclosures tied to pricing, raw-material costs, restructuring savings and acquisition or divestiture effects.
Proxy and governance filings cover annual meeting matters, director elections, auditor ratification, advisory executive-compensation votes, board committee service and director compensation arrangements. The filing record also includes exhibits and Inline XBRL cover data associated with material-event reports.
Daniel L. Florness, a director of H.B. Fuller Company (FUL), reported insider transactions dated 08/29/2025. The Form 4 discloses a disposition of 1,351 shares of common stock and the acquisition of 360.36 stock units under the Directors' Deferred Compensation Plan that convert 1-for-1 into common shares upon retirement, death, disability or certain events. The filing reports 28,794.88 shares beneficially owned following these transactions, which includes units received as dividend equivalents. The Form 4 was signed by an attorney-in-fact on 09/02/2025. All transactions are recorded as direct ownership.
H.B. Fuller Company (FUL) Executive VP & CFO John J. Corkrean reported changes in his beneficial ownership on Form 4. The filing shows a disposition of 52,196 shares of Common Stock on 08/15/2025. The report details derivative and equity holdings still held by the reporting person, including phantom units that convert 1-for-1 into common shares (159.84 units shown, representing 26,199.97 when combined with a dividend equivalent feature), multiple vested and unvested employee stock options with exercise prices ranging from $43.48 to $77.72 and individual option share counts listed (for example, 41,208, 48,309, 38,376 among others), and restricted stock units that vest in scheduled installments (examples: 1,292.02, 2,830.02, 4,335.92). The Form 4 is signed by an attorney-in-fact on behalf of the reporting person on 08/18/2025. The filing does not state a sale price for the 52,196-share disposition.
H.B. Fuller insider filing: Ms. Heather Campe, Senior Vice President, International Growth, reported transactions dated 08/15/2025. The filing shows a disposition of 22,316.23 shares of common stock in the non-derivative table. On the same date she acquired 36.77 phantom units that convert 1-for-1 into common stock under the company deferred compensation plan and acquired 36.77 underlying shares at an indicated price of $58.97. The report also lists multiple outstanding employee stock options (with strike prices $51.89, $53.57, $64.28, $68.17, $72.94, $77.72) and restricted stock units vesting over 2026–2028, with specific share amounts disclosed for each grant. The form is signed by an attorney-in-fact on 08/18/2025.
H.B. Fuller senior vice president Joao Magalhaes exercised an employee stock option for 1,099 shares of common stock at $33.38 per share on August 8, 2025, then sold 1,099 shares at $56.315 per share. After these transactions he directly holds 3,285 common shares, 27,755 employee stock options, and 1,993.84 restricted stock units.
The Form 144 for H.B. Fuller Company reports a proposed sale of 1,099 common shares through Charles Schwab with an aggregate market value of $61,890, to be sold approximately on 08/08/2025 on the NYSE. The filing states these shares were acquired on 08/08/2025 via an employee stock option exercise, with payment described as a broker payment for cashless exercise.
The notice also discloses a recent sale of 1,046 shares on 08/07/2025 generating gross proceeds of $58,787. The signer represents they do not possess any undisclosed material adverse information. Several filer-identification fields in the provided text are blank.
H.B. Fuller Sr. VP, Engineering Adhesives, Joao Magalhaes exercised employee stock options covering 1,046 shares at $34.4300 on August 7, 2025 and reported a sale of 1,046 common shares at a weighted average price of $56.2022, with prices from $56.09 to $56.275.
After these transactions, Magalhaes holds 3,285 common shares, employee stock options for 28,854 shares and 1,993.84 restricted stock units that convert into common stock on a 1-for-1 basis and vest in three annual installments.
H.B. Fuller (FUL) Form 4: Exec VP Business Transformation Nathan D. Weaver reported a modest insider sale on 08/05/2025. He disposed of 213.1901 common shares held in the company 401(k) plan at $56.84 each, shares that had been accumulated via dividend reinvestment from 04/28/2025-07/24/2025. Post-sale, the plan holds zero shares while Weaver retains 6,970 directly owned shares.
The filing also outlines substantial long-term equity exposure:
- 94,841 employee stock options (strike $26.66-$77.72, expirations 2026-2035); options granted before 2024 are fully vested, later grants vest 33%/33%/34%.
- 5,848 phantom units convertible 1-for-1 into common stock upon separation or an elected date.
- 4,298 restricted stock units vesting between 2026-2028.
No other transactions, purchases, or material corporate events were disclosed in this filing.